Literature DB >> 11984533

Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene.

Seiichi Hirota1, Toshirou Nishida, Koji Isozaki, Masahiko Taniguchi, Kazuhiro Nishikawa, Akiko Ohashi, Arimichi Takabayashi, Tadashi Obayashi, Tomoko Okuno, Kazuo Kinoshita, Hui Chen, Yasuhisa Shinomura, Yukihiko Kitamura.   

Abstract

A family with multiple gastrointestinal stromal tumors (GISTs), a new type of germline mutation of KIT gene, and dysphagia is reported. The mutation was observed at Asp-820 in tyrosine kinase (TK) II domain. Mutations in TK II domain have been found in mast cell and germ cell tumors but not in GISTs, and the present family members are the first reported cases of GISTs with TK II domain mutations, including sporadic GISTs. Because interleukin 3-dependent Ba/F3 murine lymphoid cells transfected with the mutant KIT complementary DNA grew autonomously without any growth factors and formed tumors in nude mice, the mutation was considered to be gain-of-function type. Family members with the germline KIT mutation reported dysphagia, but those without the mutation did not. The mechanism of dysphagia was examined with gastrointestinal fiberscopy, endoscopic ultrasonography, and esophageal manometry. No mechanical obstruction was found, and the esophagus was not remarkably dilated. In the family members with dysphagia, endoscopic ultrasonography at the esophagocardiac junction showed a thickened hyperechoic layer between the circular and longitudinal muscle layers, suggesting hyperplasia of interstitial cells of Cajal at the myenteric plexus layer. Manometry showed low resting lower esophageal sphincter pressure and abnormal simultaneous contractions of the esophagus without normal peristalsis. These findings indicate that the dysphagia of the present family is different from typical achalasia. This is the first report of familial dysphagia caused by germline gain-of-function mutation of the KIT gene at the TK II domain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11984533     DOI: 10.1053/gast.2002.33024

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  41 in total

1.  Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.

Authors:  Henrietta Szutorisz; Claudia Canzonetta; Andrew Georgiou; Cheok-Man Chow; László Tora; Niall Dillon
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

2.  The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.

Authors:  R Penzel; S Aulmann; M Moock; M Schwarzbach; R J Rieker; G Mechtersheimer
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

3.  [Surgical considerations for gastrointestinal stroma tumor].

Authors:  P Hohenberger; E Wardelmann
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

Review 4.  Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.

Authors:  S Farag; L E van der Kolk; H H van Boven; A C J van Akkooi; G L Beets; J W Wilmink; N Steeghs
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

5.  Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature.

Authors:  Takashi Ito; Masahiro Yamamura; Toshihiro Hirai; Takashi Ishikawa; Tatsuo Kanda; Takuya Nakai; Mizuka Ohkouchi; Yuka Hashikura; Koji Isozaki; Seiichi Hirota
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 6.  An update on molecular genetics of gastrointestinal stromal tumours.

Authors:  L Tornillo; L M Terracciano
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

7.  Hereditary gastrointestinal cancer syndromes.

Authors:  Henry T Lynch; Jane F Lynch; Trudy G Shaw
Journal:  Gastrointest Cancer Res       Date:  2011-07

Review 8.  [Gastrointestinal stromal tumors. A morphologic and molecular genetic independent tumor entity with new therapeutic perspectives].

Authors:  G Mechtersheimer; T Lehnert; R Penzel; S Joos; G Egerer; H F Otto
Journal:  Pathologe       Date:  2003-03-21       Impact factor: 1.011

Review 9.  Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib.

Authors:  Gunhild Mechtersheimer; Gerlinde Egerer; Manfred Hensel; Ralf J Rieker; Martin Libicher; Thomas Lehnert; Roland Penzel
Journal:  Virchows Arch       Date:  2004-01-20       Impact factor: 4.064

10.  An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors.

Authors:  Tsuyoshi Takahashi; Kiyokazu Nakajima; Akiko Nishitani; Yoshihito Souma; Seiichi Hirota; Yoshiki Sawa; Toshirou Nishida
Journal:  Int J Clin Oncol       Date:  2007-10-22       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.